TrialThe Lancet. Infectious diseases2017

Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.

Punnee Pitisuttithum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.